FIPRA welcomes Karen Facey as Senior Advisor on Health Technology Assessment

We are delighted to welcome Karen Facey, PhD CStat HonMFPH, to FIPRA Public Affairs as our Senior Advisor on Health Technology Assessment.

With her extensive experience and expertise in health policy, HTA (Health Technology Assessment), and patient involvement, Karen brings a wealth of knowledge and insight to our team.

Karen has an impressive background, having worked as a senior statistician in the pharmaceutical sector and medicines regulation, and as the founding Chief Executive of the first national HTA agency in Scotland. 

She has been an independent consultant on health policy, HTA, and patient involvement since 2003, and has served as a Non-Executive Director on Scottish health boards for a decade. She has also chaired a Scottish Government committee to develop the national resource allocation for the NHS.

It’s great to be collaborating more closely  with the FIPRA team, working to enable effective multi-stakeholder dialogues and delivering impactful outcomes.

– Karen Facey, Senior Advisor Health Technology Assessment

Karen is a Visiting Senior Research Fellow at the University of Edinburgh, where she has led research on the appraisal of rare disease treatments. She is passionate about holistic HTA to determine value and the use of health service data to improve patient care. She also facilitates the RWE4Decisions multi-stakeholder initiative commissioned by INAMI.

We are excited to have Karen on board as a valuable addition to our team, and look forward to working with her to facilitate meaningful dialogues and achieve positive results.